Bayer will be paying $10.5 billion to settle U.S. claims that Roundup, its weedkiller, has lead to cancer in nearly 100,000 patients.
Bayer AG introduced on Wednesday it struck an about $10.5 billion deal to work out countless claims with U.S. complainants affirming the firm’s Roundup herbicide causes cancer. Wednesday’s deal complies with months of talks between Bayer and also plaintiffs’ lawyers.
Bayer, which additionally makes pharmaceuticals, inherited countless legal actions against Roundup’s developer Monsanto Co. when it acquired the U.S. farming titan in 2018. Bayer has actually argued that Roundup is safe and also has repetitively protected the Monsanto bargain.
As part of the case, Bayer will pay some $9.5 billion to settle claims brought by attorneys standing for some 95,000 plaintiffs. It will set aside an added roughly $1.1 billion to establish and fund a panel to examine whether the item causes cancer cells to support future cases.
Bayer to pay $10.5B to settle 100,000 Roundup cancer claims in US
Politico
Bayer has agreed to pay about $10.5 billion to settle claims in the U.S. that its weedkiller Roundup led to cancer in nearly 100,000 patients exposed to the popular herbicide, according to a law firm representing some of the plaintiffs.
Read More >>
Bayer to Pay Up to $10.9 Billion to Settle Lawsuits Over Roundup Weedkiller
Wall Street Journal
Bayer AG said Wednesday it would pay up to $10.9 billion to settle tens of thousands of lawsuits with U.S. plaintiffs alleging the company’s Roundup herbicide causes cancer, a milestone in the German company’s legal battle that has been weighing down its share price for nearly two years.
Read More >>
Roundup Maker to Pay $10 Billion to Settle Cancer Suits
The New York Times
Bayer faced tens of thousands of claims linking the weedkiller to cases of non-Hodgkin’s lymphoma. Some of the money is set aside for future cases.
Read More >>
Bayer agrees to pay $10 billion to settle Roundup weedkiller cancer claims
Axios
Bayer has agreed to pay just over $10 billion in order to settle roughly 125,000 claims that its Roundup weedkiller cases cancer and resolve potential future litigation, the company announced on Wednesday.
Read More >>
Bayer reaches $10.5 billion Roundup settlement
Market Watch
Bayer AG is set to announce on Wednesday it struck a roughly $10.5 billion deal to settle tens of thousands of lawsuits with U.S. plaintiffs alleging the company’s Roundup herbicide causes cancer, a milestone in the German company’s legal battle that has been weighing down its share price for nearly two years, according to a person familiar with the deal.
Read More >>
Have you or a loved one been impacted by Roundup?
Contact us below to learn about your options.
Tracy Everhart
Tracy Everhart is the Editor for Drug Law Journal. A highly-trained and certified medical professional, Tracy is also an accomplished medical writer. After spending years on the front lines of the medical profession, Tracy now devotes her expertise and skills to researching and reporting on new drugs and devices that enter the market, as well as their side-effects and the real-life stories involved. Prior to joining Drug Law Journal, Tracy wrote for benchmark online healthcare resources focused on families and, in particular, women’s health issues. Tracy holds post-graduate degrees from both the American College of Healthcare Sciences and the Yale School of Nursing. She is also a graduate of both Hampshire College, where she studied microbiology and the University of South Carolina school of nursing.